| 000 | 01901 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516231301.0 | ||
| 264 | 0 | _c20150105 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1742-4658 | ||
| 024 | 7 |
_a10.1111/febs.13021 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHayashi, Takanori | |
| 245 | 0 | 0 |
_aPost-translational dual regulation of cytochrome P450 aromatase at the catalytic and protein levels by phosphorylation/dephosphorylation. _h[electronic resource] |
| 260 |
_bThe FEBS journal _cNov 2014 |
||
| 300 |
_a4830-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xpharmacology |
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAromatase _xmetabolism |
| 650 | 0 | 4 |
_aCalcium _xpharmacology |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinase Type 2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCatalysis _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell-Free System |
| 650 | 0 | 4 |
_aChoriocarcinoma _xpathology |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacology |
| 650 | 0 | 4 |
_aCytosol _xenzymology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMagnesium _xpharmacology |
| 650 | 0 | 4 |
_aMicrosomes _xenzymology |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xmetabolism |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
| 650 | 0 | 4 |
_aProteolysis _xdrug effects |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xmetabolism |
| 650 | 0 | 4 |
_aTacrolimus _xpharmacology |
| 700 | 1 | _aHarada, Nobuhiro | |
| 773 | 0 |
_tThe FEBS journal _gvol. 281 _gno. 21 _gp. 4830-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/febs.13021 _zAvailable from publisher's website |
| 999 |
_c24131789 _d24131789 |
||